Viewing StudyNCT00266552



Ignite Creation Date: 2024-05-05 @ 12:10 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00266552
Status: COMPLETED
Last Update Posted: 2011-01-24
First Post: 2005-12-16

Brief Title: A Study of the Safety and Effectiveness of Risperidone Versus Placebo for the Treatment of Conduct Disorder in Children With Mild Moderate or Borderline Mental Retardation
Sponsor: Janssen Pharmaceutica NV Belgium
Organization: Janssen Pharmaceutica NV Belgium

Conditions & Keywords Data

Conditions:
Name
Oppositional Defiant Disorder
Conduct Disorder
Disruptive Behavior Disorder
Keywords:
Name View
children View
conduct disorder View
oppositional defiant disorder View
disruptive behavior disorder not otherwise specified View
ADHD View
risperidone View
antipsychotropic agents View